Baseline demographic characteristics of patients with acute cholecystitis who underwent percutaneous cholecystostomy tube placement
| Characteristic | No. (%) of patients* n = 140 |
|---|---|
| Age, mean ± SD; yr | 68.4 ± 17.7 |
| Male sex | 76 (54.3) |
| Weight, mean ± SD; kg | 84.4 ± 20.2 |
| Laboratory values, mean ± SD | |
| Leukocyte count, × 109/L | 14.4 ± 6.3 |
| Hemoglobin level, g/L | 117 ± 19.7 |
| Comorbidities | |
| Respiratory | 48 (34.3) |
| Cardiac | 98 (70.0) |
| Metabolic | 64 (45.7) |
| Gastrointestinal | 34 (24.3) |
| Renal | 26 (18.6) |
| Hepatic | 10 (7.1) |
| Malignant disease | 27 (19.3) |
| Steroid use | 5 (3.6) |
| Received anticoagulant treatment | 30 (21.4) |
| Previous abdominal surgery | 53 (37.8) |
| Radiological findings | |
| Dilated gallbladder (n = 111) | 94 (84.7) |
| Gallbladder wall thickness ≥ 4 mm (n = 122) | 110 (90.2) |
| Pericholecystic fat stranding (n = 97) | 79 (81.4) |
| Cholelithiasis (n = 113) | 92 (81.4) |
SD = standard deviation.
↵* Except where noted otherwise.